Onkologie. 2011:5(2):87-90
Breakthrough cancer pain: clinical characteristics and modern strategies to its management
- Ambulance podpůrné a paliativní onkologie, Klinika komplexní onkologické péče, MOU, Brno
Breakthrough pain (BP) is a transient exacerbation of pain in patient with stable and adequatly controled background pain. The prevalenco
o BP is 40–70 % among cancer patients. Pathophysiologic chracter of BP is usually linked to the character of background pain. The
management of BP has to be „tailored“ individualy and combines pharmacological and non-pharmacological approaches. Transmucosal
fentanyl formulations represent an important and interesting progress in BP management.
Keywords: breakthrough pain, background pain, rescue medication, transmucousal fentanyl
Published: April 1, 2011 Show citation
References
- Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: an integrated approach. In: Doyle D, Hanks G, Cherny N, Calman K, editors. Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press, 2004: 438-458.
- Sláma O, Lejčko J, Kozák J, et al. Epidemiologie a léčba průlomové bolesti u onkologických pacientů v ČR. Bolest 2011; 14(1): 158-160.
- Haugen DF, Hjermstad MJ, Hagen N, et al. Assessment and classification of cancer breakthrough pain: A systematic literature review. Pain 2010; 149: 476-482.
Go to original source... 
Go to PubMed... - Wu JS, Monk G, Clark T, et al. Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol 2006; 18(7): 539-544. Go to original source... Go to PubMed...
- Ripamonti C, Fagnoni E, Campa T, Seregni E, Maccauro M, Bombardieri E. Incident pain and analgesic consumption decrease after samarium infusion: a pilot study. Supp Care Cancer 2007; 15: 339-342. Go to original source... Go to PubMed...
- Ripamonti C, Fagnoni E, Campa T, Giardina V, Brunelli C, Pigni A, et al. Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study. Supp Care in Cancer 2007; 15: 1177-1184. Go to original source... Go to PubMed...
- Burton AW, Reddy SK, Shah HN, et al. Percutaneous vertebroplasty: a technique to treat refractory spinal pain in the setting of advanced metastatic cancer. A case series. J Pain Symptom Manage 2005; 30(1): 87-95. Go to original source... Go to PubMed...
- Mercadante S, Villari P, Ferrera P, Casuccio A. Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Sympt Manage 2004; 28: 505-510. Go to original source... Go to PubMed...
- Vondráčková D. Nové cesty léčení průlomové bolesti. Bolest 2009; 12(3): 153-160.
- Nosková P. Průlomová bolest a její léčba. Onkologie 2010; 4(2): 94-100.
- Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006; 1: CD004311. Go to original source... Go to PubMed...